Clinical Trials

Meningioma

NCT05278208 2026-04-13

Lutathera for Treatment of Recurrent or Progressive High-Grade CNS Tumors

Phase 1/2 Recruiting

65 enrolled

Diffuse Intrinsic Pontine Glioma, Ependymoma, Glioma, Medulloblastoma, Meningioma, Neoplasms, Germ Cell and Embryonal, Central Nervous System Neoplasms

NCT02523014 2026-04-07

Vismodegib, FAK Inhibitor GSK2256098, Capivasertib, and Abemaciclib in Treating Patients With Progressive Meningiomas

124 enrolled

Meningioma

NCT06275919 2026-03-27

MIRAGE

104 enrolled

Meningioma

NCT07413796 2026-03-27

NEURO-SUTURE

382 enrolled

Brain Neoplasms, Glioblastoma, Glioma, Meningioma

NCT07497984 2026-03-27

ITM11 Expanded Access Program

Available

Phase EARLY_PHASE1 Not yet recruiting

Meningioma

NCT07493447 2026-03-25

Pilot Study Evaluating Panitumumab-IRDye800 as an Optical Imaging Agent to Detect Intracranial Lesions During Neurosurgical Procedures

30 enrolled

CNSEndocrine

Brain Neoplasms, Glioblastoma, Meningioma, Neoplasms, Neuroma, Acoustic, Pituitary Neoplasms

NCT04189172 2026-03-18

MiDura

Active not recruiting

328 enrolled

Arnold-Chiari Malformation, Brain Neoplasms, Hydrocephalus, Meningioma, Spinal Cord Injuries, Vascular Malformations

NCT07476404 2026-03-17

GM-HES

Completed

300 enrolled

Meningioma

NCT05940493 2026-03-13

Abemaciclib in Newly Diagnosed Meningioma Patients

72 enrolled

Meningioma

NCT03971461 2026-03-11

Phase II Study of 177Lu-DOTATATE Radionuclide in Adults With Progressive or High-risk Meningioma

32 enrolled

Meningioma

NCT06104930 2026-03-10

MOLI

60 enrolled

Phase EARLY_PHASE1 Active not recruiting

Meningioma

NCT02933736 2026-03-06

Ribociclib (LEE011) in Preoperative Glioma and Meningioma Patients

48 enrolled

Glioblastoma, Meningioma

NCT05425004 2026-03-05

Cabozantinib for Patients With Recurrent or Progressive Meningioma

24 enrolled

Phase 2 Not yet recruiting

Meningioma, Central Nervous System Neoplasms

NCT04298541 2026-02-27

Direct Comparison of Ga-68-DOTATATE and Ga-68-DOTATOC

6 enrolled

Meningioma

NCT06377371 2026-02-27

Feasibility of Intraoperative Tracing of Meningioma Using [Cu64]DOTATATE

Phase 4 Recruiting

20 enrolled

Phase 2 Not yet recruiting

Meningioma

NCT07428616 2026-02-24

A Study of Zanzalintinib in Participants With Recurrent or Progressive Meningioma

100 enrolled

Phase NA Not yet recruiting

Brain Neoplasms, Meningioma

NCT07428213 2026-02-23

PIVIM

40 enrolled

Meningioma

NCT06878469 2026-02-19

SIMPLIF-AI

200 enrolled

Brain Neoplasms, Meningioma

NCT07418775 2026-02-18

Tumor Genomics, Individual Risk Factors, and External Drivers of Health on Health Outcomes for Patients With Meningioma

Not yet recruiting

3,000 enrolled

Brain Neoplasms, Meningioma

NCT04278118 2026-02-17

HiPPI

70 enrolled

CNSEndocrine

Brain Neoplasms, Meningioma, Neurilemmoma, Pituitary Neoplasms, Nerve Sheath Neoplasms

NCT07411690 2026-02-17

CSF-IMR

Recruiting

200 enrolled

Brain Neoplasms, Glioblastoma, Glioma, Meningioma, Cerebrospinal Fluid Leak

NCT04427384 2026-02-13

Registry of Patients With Brain Tumors Treated With STaRT (GammaTiles)

Recruiting

600 enrolled

Brain Neoplasms, Meningioma

NCT05957679 2026-02-12

MRE Evaluation for Spinal Cord Tumor Surgery: Stiffness and Adhesion Assessment

20 enrolled

Astrocytoma, Ependymoma, Glioblastoma, Glioma, Meningioma, Neurofibroma, Spinal Cord Neoplasms

NCT06955208 2026-02-12

3D MRE-Based Evaluation of Meningioma Mechanical Properties and Histological Features

300 enrolled

Tissue Adhesions, Meningioma

NCT06132685 2026-02-10

Post-Operative Dosing of Dexamethasone in Patients With Brain Tumors After a Craniotomy, PODS Trial

200 enrolled

Brain Neoplasms, Meningioma

NCT07282470 2026-02-10

MIND

Recruiting

210 enrolled

Phase NA Not yet recruiting

Meningioma

NCT07398066 2026-02-09

DEX-NEURO

60 enrolled

Phase NA Not yet recruiting

Brain Neoplasms, Delirium, Meningioma, Pain

NCT07398170 2026-02-09

BIOLIMEN-1

15 enrolled

Meningioma, Neoplastic Cells, Circulating, Neoplasm Recurrence, Local

NCT05139277 2026-02-06

Evaluation of the CONVIVO System

30 enrolled

CNSEndocrine

Brain Neoplasms, Glioblastoma, Glioma, Meningioma, Neurilemmoma, Pituitary Neoplasms

NCT06650163 2026-02-05

Zr-89 Crefmirlimab Berdoxam and Immuno-Positron Emission Tomography for the Imaging of Patients With Resectable Brain Tumors

Phase 1 Recruiting

20 enrolled

Brain Neoplasms, Glioma, Meningioma

NCT07376473 2026-02-03

MenQOL 2

Not yet recruiting

238 enrolled

Meningioma

NCT03279692 2026-01-29

Phase II Trial of Pembrolizumab in Recurrent or Residual High Grade Meningioma

26 enrolled 14 charts

Meningioma

NCT02648997 2026-01-26

An Open-Label Phase II Study of Nivolumab or Nivolumab/Ipilimumab in Adult Participants With Progessive/ Recurrent Meningioma

40 enrolled 14 charts

Meningioma

NCT06012929 2026-01-26

A Study of ONC201 for Refractory Meningioma

Phase 2 Withdrawn

Meningioma

NCT07353229 2026-01-23

68Ga-Dotatate PET and MRI Guided Radiation Dose Escalation for High Risk Meningioma

Phase 1 Suspended

24 enrolled

Meningioma

NCT06752096 2026-01-16

Robot-Assisted Neurovascular Intervention

10 enrolled

Ischemic Stroke, Meningioma, Stroke

NCT03180268 2026-01-14

Observation or Radiation Therapy in Treating Patients With Newly Diagnosed Grade II Meningioma That Has Been Completely Removed by Surgery

Phase 3 Recruiting

163 enrolled

Meningioma

NCT04374305 2026-01-12

INTUITT-NF2

100 enrolled

Ependymoma, Meningioma, Neuroma, Acoustic, Neurofibromatosis 2

NCT04113408 2026-01-06

MENTHE

Terminated

315 enrolled

Meningioma

NCT04113395 2026-01-05

CAMOMILLE

Completed

514 enrolled

Meningioma

NCT06322342 2025-12-26

Phase 2 Ascending Dose Safety and Efficacy Study of RVP-001, a Manganese-based MRI Contrast Agent

Phase 2 Completed

18 enrolled

Neuroinflammatory Diseases, Brain Neoplasms, Glioma, Meningioma, Multiple Sclerosis, Neoplasms, Neurilemmoma, Neurofibroma, Neuroma, Acoustic, Central Nervous System Neoplasms

NCT07150806 2025-12-22

RYZ101 for the Treatment of Progressive or Recurrent Intracranial Meningioma

Phase 1/2 Recruiting

30 enrolled